We want you to be Well Informed.

Nothing beats being in the know. When you subscribe to WellInformed, our quarterly newsletter, you get the latest industry news, access to drug pipeline reports, insight into new FDA-approved drugs and much more.

In the 2nd Quarter edition of WellInformed, we included articles about Jeff Park joining the company as our new Chairman and CEO, our annual Drug Trend Report, and information about our July 1, 2019 formulary updates. We also announce a new honor bestowed upon our wholly-owned specialty pharmacy, US Specialty Care (USSC). Finally, we included updates about our WellConnect Member Digital Engagement Solution, industry-leading adherence rates, orphan drugs, upcoming events, and new FDA approved drugs.
Read articles about our WellManaged - Heart Failure program and our partnerships with DaVita and Relay Network. This edition also includes our 1H 2019 pipeline reports, information about our WellManaged - Migraines program, IRS High Deductible Health Plan (HDHP) rules, upcoming events, and a listing of FDA-approved drugs.
This edition includes information about National Diabetes Month, Q1 2019 formulary changes, and updates to the Affordable Care Act (ACA) preventive care coverage guidelines. We also discuss our WellManaged - Clinical Programs, Mail Order Pharmacy, and a new accreditation bestowed upon US Specialty Care (USSC).
In this edition of Well Informed, you’ll find information about our October 1, 2018 utilization management enhancements, Outsourced Pharmacy Solutions, the importance of vaccinations, and the efficacy of our WellManaged – Diabetes program. We also review industry events we attended and recently-approved FDA drugs.

Please complete the form to below to obtain a copy of the newsletter(s).

Interested in upcoming WellDyneRx events?